Accueil   Agenda - News   Toutes les news EDAP Announces Focal One® HIFU Sale to Foch Hospital

EDAP Announces Focal One® HIFU Sale to Foch Hospital

Growing Adoption of Focal One HIFU in France


EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale of a Focal One® system to Foch Hospital, Paris, one of the largest private hospitals in the Paris Area.


Pr. Thierry Lebret, Head of Urology and Kidney Transplantation Department at Foch Hospital and recently appointed President of the French Urology Association, commented: "Our team is enthusiastic about the acquisition of Focal One HIFU as it responds to a growing demand for more non-invasive prostate cancer treatments. This innovative system adds to our portfolio of solutions offered to prostate cancer patients. Focal One combines state-of-the-art IRM and real-time ultrasound imaging capabilities with targeted HIFU technology to allow precise ablation of prostatic tissue, with reduced side effects."

Lire le communiqué de presse